Published in Vaccine on October 26, 2007
Cross-border transport of rescue dogs may spread rabies in Europe. Vet Rec (2015) 1.41
Achieving population-level immunity to rabies in free-roaming dogs in Africa and Asia. PLoS Negl Trop Dis (2014) 0.96
Factors associated with the success of rabies vaccination of dogs in Sweden. Acta Vet Scand (2011) 0.93
Review on dog rabies vaccination coverage in Africa: a question of dog accessibility or cost recovery? PLoS Negl Trop Dis (2015) 0.91
X-linked myotubular myopathy in Rottweiler dogs is caused by a missense mutation in Exon 11 of the MTM1 gene. Skelet Muscle (2015) 0.79
Effects of body weight on antibody titers against canine parvovirus type 2, canine distemper virus, and canine adenovirus type 1 in vaccinated domestic adult dogs. Can J Vet Res (2012) 0.79
Neutralizing antibody response in dogs and cats inoculated with commercial inactivated rabies vaccines. J Vet Med Sci (2013) 0.76
Serum antibody responses to vaccinal antigens in lean and obese geriatric dogs. Can Vet J (2016) 0.75
Evaluation of phenotypic factors for anti-rabies antibody in vaccinated pet dogs. Virusdisease (2015) 0.75
Restricted dog leucocyte antigen (DLA) class II haplotypes and genotypes in Beagles. Vet J (2015) 0.75
Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2. Acta Vet Scand (2017) 0.75
Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study. Arthritis Rheum (2007) 3.99
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum (2002) 3.53
Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet (2012) 3.48
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet (2010) 3.24
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) (2010) 3.04
A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special? Proc Biol Sci (2013) 2.56
The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol (2005) 2.48
Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med (2006) 2.41
HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.28
Rabies encephalitis in malaria-endemic area, Malawi, Africa. Emerg Infect Dis (2007) 2.21
Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum (2003) 2.20
Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum (2004) 2.19
Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum (2005) 2.14
Next generation sequencing of viral RNA genomes. BMC Genomics (2013) 2.10
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis (2011) 1.99
Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS One (2010) 1.95
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis (2012) 1.80
Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population. Spine (Phila Pa 1976) (2003) 1.79
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
Public health threat of new, reemerging, and neglected zoonoses in the industrialized world. Emerg Infect Dis (2010) 1.74
The genetic basis of individual-recognition signals in the mouse. Curr Biol (2007) 1.68
Lateral wedge insoles as a conservative treatment for pain in patients with medial knee osteoarthritis: a meta-analysis. JAMA (2013) 1.67
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis (2007) 1.66
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum (2002) 1.66
Pivotal role of dogs in rabies transmission, China. Emerg Infect Dis (2005) 1.64
Evaluation of the genetic overlap between osteoarthritis with body mass index and height using genome-wide association scan data. Ann Rheum Dis (2012) 1.62
A framework for the study of zoonotic disease emergence and its drivers: spillover of bat pathogens as a case study. Philos Trans R Soc Lond B Biol Sci (2012) 1.61
The genetic basis of inbreeding avoidance in house mice. Curr Biol (2007) 1.61
Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis. J Rheumatol (2009) 1.60
A variant in MCF2L is associated with osteoarthritis. Am J Hum Genet (2011) 1.60
Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet. Emerg Infect Dis (2012) 1.59
Rabies in China: an update. Vector Borne Zoonotic Dis (2008) 1.57
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis (2012) 1.56
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis. Rheumatology (Oxford) (2011) 1.55
Bats and lyssaviruses. Adv Virus Res (2011) 1.54
Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis (2006) 1.53
Antibodies against Lagos bat virus in megachiroptera from West Africa. Emerg Infect Dis (2008) 1.53
Preliminary study of dengue virus infection in Iran. Travel Med Infect Dis (2012) 1.49
Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J Allergy Clin Immunol (2007) 1.45
Rabies emergence among foxes in Turkey. J Wildl Dis (2003) 1.43
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008. Rheumatology (Oxford) (2010) 1.43
Incidence of cancer among UK Gulf war veterans: cohort study. BMJ (2003) 1.43
NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J Immunol (2010) 1.41
Rabies virus in a dog imported to the UK from Sri Lanka. Vet Rec (2008) 1.40
Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med (2005) 1.40
The immune response to rabies virus infection and vaccination. Vaccine (2010) 1.34
Passive immunity in the prevention of rabies. Lancet Infect Dis (2012) 1.31
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology (Oxford) (2010) 1.30
Predictors of hip joint replacement in new attenders in primary care with hip pain. Br J Gen Pract (2003) 1.29
Flavivirus-induced antibody cross-reactivity. J Gen Virol (2011) 1.28
Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J Gen Virol (2008) 1.27
Case report: rapid ante-mortem diagnosis of a human case of rabies imported into the UK from the Philippines. J Med Virol (2003) 1.25
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis (2006) 1.25
A universal real-time assay for the detection of Lyssaviruses. J Virol Methods (2011) 1.24
When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2004) 1.24
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther (2006) 1.23
Molecular epidemiology of terrestrial rabies in the former Soviet Union. J Wildl Dis (2004) 1.23
European bat lyssavirus in Scottish bats. Emerg Infect Dis (2005) 1.22
Renewed global partnerships and redesigned roadmaps for rabies prevention and control. Vet Med Int (2011) 1.22
Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis (2009) 1.21
Genomic sequence of the class II region of the canine MHC: comparison with the MHC of other mammalian species. Genomics (2005) 1.21
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford) (2013) 1.21
Towards a 'One Health' research and application tool box. Vet Ital (2010) 1.19
The risk of infection associated with tumor necrosis factor alpha antagonists: making sense of epidemiologic evidence. Arthritis Rheum (2008) 1.18
Bat flight and zoonotic viruses. Emerg Infect Dis (2014) 1.17
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum (2007) 1.16
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum (2004) 1.16
Opportunities for prevention of 'clinically significant' knee pain: results from a population-based cross sectional survey. J Public Health (Oxf) (2004) 1.16
Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann Rheum Dis (2012) 1.14
Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res Ther (2006) 1.13
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum (2013) 1.12
Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Vaccine (2007) 1.10
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity. Rheumatology (Oxford) (2009) 1.10
Determining aspects of ethnicity amongst persons of South Asian origin: the use of a surname-classification programme (Nam Pehchan). Public Health (2007) 1.09
Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization. Nucleic Acids Res (2013) 1.09
A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis (2008) 1.08
Demography of straw-colored fruit bats in Ghana. J Mammal (2012) 1.07
Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife. Vaccine (2008) 1.07
Investigation of a human case of rabies in the United Kingdom. J Clin Virol (2002) 1.07
Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg (2003) 1.06
Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Health Qual Life Outcomes (2010) 1.06
Paralytic rabies after a two week holiday in India. BMJ (2005) 1.06
The direct assessment of genetic heterozygosity through scent in the mouse. Curr Biol (2008) 1.05
Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register. Arthritis Care Res (Hoboken) (2012) 1.05
Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Immunogenetics (2003) 1.05
Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum (2002) 1.05
Model-guided fieldwork: practical guidelines for multidisciplinary research on wildlife ecological and epidemiological dynamics. Ecol Lett (2012) 1.04
Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles. J Infect Dis (2002) 1.04
The effect of genome-wide association scan quality control on imputation outcome for common variants. Eur J Hum Genet (2011) 1.04
Detection of mosquito-only flaviviruses in Europe. J Gen Virol (2012) 1.04
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy. Rheumatology (Oxford) (2010) 1.02
Primary care consultation predictors in men and women: a cohort study. Br J Gen Pract (2005) 1.02
Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis (2012) 1.02